SMC accepts letermovir for use within NHS Scotland for appropriate patients.

SMC accepts MSD’s PREVYMIS®▼ for use in NHS Scotland

The Scottish Medicines Consortium (SMC) has accepted MSD's PREVYMIS®▼ (letermovir) for use within NHS Scotland for prophylaxis of cytomegalovirus (CMV) reactivation and disease in...
The European Commission approves Roche's Tecentriq in combination with Avastin

The EC approves Tecentriq in combination with Avastin

The European Commission approves Roche's Tecentriq in combination with Avastin and chemotherapy for the initial treatment of metastatic lung cancer Roche has announced that the...
AstraZeneca to present data evaluating CV effects of Farxiga.

AstraZeneca to present Farxiga CV data at ACC 2019

Data evaluating the cardiovascular (CV) effects of Farxiga (dapagliflozin), including hospitalisation for heart failure (hHF) in adults with type-2 diabetes (T2D) have been selected...
European marketing authorisation application for darolutamide

European marketing authorisation application for darolutamide

Orion Corporation and Bayer have announced that a European marketing authorisation application has been submitted for darolumatide. The companies have submitted the marketing authorisation application to the...
Alzheimer's Society says women should not be alarmed over small hormone therapy risk.

Alzheimer’s Society’s advice over hormone therapy ‘risk’

A study by researchers at University of Helsinki, published in the BMJ, suggested that long term use of oral hormone therapy could be associated...
The National Institute for Health and Care Excellence has requested further evidence on blinatumomab for adults with acute lymphoblastic leukaemia.

NICE requests more evidence on blinatumomab for acute lymphoblastic leukaemia

The National Institute for Health and Care Excellence (NICE) has requested further evidence on blinatumomab for the treatment of adults with acute lymphoblastic leukaemia. The committee...
Integrated care underpins new NHS plan

Software platform to accelerate pharma innovation launched

Linum Labs, a software development studio that builds blockchain-based solutions, has announced the launch of Molecule, a software platform and marketplace to accelerate innovation...
Astellas submits EMA MAA for XOSPATA (gilteritinib)

EMA accepts marketing authorisation application for XOSPATA (gilteritinib)

Astellas Pharma Inc has announced that the submission for a marketing authorisation application for the oral once-daily therapy XOSPATA (gilteritinib) for the treatment of...
Pelmeg® a biosimilar of pegfilgrastim launched

Napp launches Pelmeg® a biosimilar of pegfilgrastim in the UK

Napp Pharmaceuticals Limited has announced the launch of Pelmeg® a biosimilar of pegfilgrastim in the UK, following European Commission (EC) approval in November 2018. Pelmeg®...
Ageing of the medical workforce is a growing trend BMA research reveals.

Ageing of medical workforce is growing trend

The NHS workforce is ageing and employers must do more to support older doctors, according to a new report by the British Medical Association...

Latest articles

Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners

Pf Award Winners on the positive patient outcomes that come from working together

The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...

Popular articles

Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Image of graduates: skills shortage in life sciences

Addressing the skills shortage in life sciences

How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...